Baird Medical Showcases Innovative MWA Technology at AAES 2025 Annual Meeting

Baird Medical at AAES 2025: Advancing Endocrine Surgery Innovation



On May 19, 2025, Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), recognized globally for its minimally invasive Microwave Ablation (MWA) technology, engaged with leaders in the field of endocrine surgery at the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES). The event took place at the Baird Center in Milwaukee, Wisconsin from May 17-19, 2025.

The AAES Annual Meeting serves as a crucial gathering for endocrine surgeons, researchers, and innovators who gather to share advancements, clinical insights, and innovations in endocrine surgery. For Baird Medical, this event provided an essential platform to highlight its state-of-the-art MWA technology specifically designed for the treatment of thyroid nodules. This innovative technique presents a minimally invasive alternative compared to traditional surgical approaches.

During the meeting, Baird Medical presented the advantages of its MWA system which significantly reduces procedural risks while improving patient outcomes. Surgeons in attendance expressed a keen interest in the technology, acknowledging its capability to preserve thyroid function and shorten recovery times.

The dialogue between the Baird Medical team and clinical experts proved invaluable, yielding critical feedback on various aspects such as patient selection, optimization of ultrasound guidance, and exploring new application scenarios. These discussions not only reinforced the effectiveness of the technology but also played an instrumental role in informing Baird Medical's future clinical collaboration strategies.

As Baird Medical continues to develop its MWA offerings, maintaining strong connections with the medical community remains a priority. The insights gathered from AAES 2025 are expected to shape the Company's initiatives aimed at advancing treatment solutions for thyroid and other endocrine diseases.

About Baird Medical


Baird Medical is an innovative medical device company focused on minimally invasive diagnostics and treatment. The company is committed to advancing surgical robotic systems and developing groundbreaking surgical instruments to enhance patient outcomes through precise technology. They work diligently to foster strategic collaborations with top academic institutions to drive research and innovation. Baird Medical's vision transcends traditional surgical assistance, aiming to create intelligent systems that proactively support diagnostic decisions and preventive care strategies. The company has achieved FDA 510(k) certification, with its solutions currently utilized in over 30 prominent hospitals and clinics across the United States, including esteemed institutions like Johns Hopkins Hospital, Tulane Medical Center, and Weill Cornell Medicine. Furthermore, Baird Medical leads the market in China for thyroid microwave ablation devices and consumables and is progressively establishing a commercial footprint in over 20 countries.

Forward-Looking Statements


This article contains forward-looking statements, which may involve risks and uncertainties that could cause actual results to differ materially from those anticipated. Readers are cautioned against placing undue reliance on any forward-looking statements, which speak only as of the date they are made. Baird Medical disclaims any obligations to update these statements.

For more information, please contact:
Eric Huang
PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: [email protected]

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.